Newsletter
FDA Calendar
Market Data
Heat Map
Screener
Insider Trades
LOGIN
|
REGISTER
Index
Newsroom
Featured Stocks
Free Daily Newsletter
Stock Lists
See All Health Stock Lists
Biotechnology Stocks
Pharmaceutical Stocks
Big Pharma Stocks
Healthcare Stocks
Medical Stocks
Diagnostics & Research Stocks
Medical Device Stocks
Biotechnology News
Pharmaceutical News
Medical News
Healthcare News
Register
FDA Calendar
Market Data
Stock Screener
Insider Trades
Search
Logout
Newsroom
Featured Stocks
Stock Lists
Biotech
Pharma
Medical
Healthcare
Watch List
Recent Insider Transactions - Bicara Therapeutics (NASDAQ: BCAX)
Follow
NASDAQ:BCAX
Visit website
Company
Name / Role
Date
Type
Price
# Shares
Value
Balance
NASDAQ
BCAX
Bicara Therapeutics
Cohlhepp Ryan
/
director, officer: President and COO
10/15/2025
Buy
$3.79
8,000
$30K
210,641
NASDAQ
BCAX
Bicara Therapeutics
Cohlhepp Ryan
/
director, officer: President and COO
10/15/2025
Sell
$18.16
8,000
$145K
202,641
NASDAQ
BCAX
Bicara Therapeutics
Cohlhepp Ryan
/
director, officer: President and COO
10/15/2025
Sell
$18.16
4,500
$82K
198,141
NASDAQ
BCAX
Bicara Therapeutics
Cohlhepp Ryan
/
director, officer: President and COO
10/15/2025
Sell
$3.79
8,000
$30K
157,334
NASDAQ
BCAX
Bicara Therapeutics
Mazumdar Claire
/
director, officer: Chief Executive Officer
10/15/2025
Buy
$3.79
13,289
$50K
323,181
NASDAQ
BCAX
Bicara Therapeutics
Mazumdar Claire
/
director, officer: Chief Executive Officer
10/13/2025
Buy
$3.79
11,445
$43K
321,337
NASDAQ
BCAX
Bicara Therapeutics
Mazumdar Claire
/
director, officer: Chief Executive Officer
10/13/2025
Sell
$3.79
11,445
$43K
314,662
NASDAQ
BCAX
Bicara Therapeutics
Mazumdar Claire
/
director, officer: Chief Executive Officer
10/15/2025
Sell
$18.84
13,289
$250K
309,892
NASDAQ
BCAX
Bicara Therapeutics
Mazumdar Claire
/
director, officer: Chief Executive Officer
10/13/2025
Sell
$18.92
11,445
$217K
309,892
NASDAQ
BCAX
Bicara Therapeutics
Mazumdar Claire
/
director, officer: Chief Executive Officer
10/15/2025
Sell
$3.79
13,289
$50K
301,373
NASDAQ
BCAX
Bicara Therapeutics
Raben David
/
officer: Chief Medical Officer
10/09/2025
Sell
$3.79
22,000
$83K
128,870
NASDAQ
BCAX
Bicara Therapeutics
Raben David
/
officer: Chief Medical Officer
10/09/2025
Buy
$3.79
22,000
$83K
57,497
NASDAQ
BCAX
Bicara Therapeutics
Raben David
/
officer: Chief Medical Officer
10/09/2025
Sell
$18.45
22,000
$406K
35,497
NASDAQ
BCAX
Bicara Therapeutics
Hyep Ivan
/
officer: Chief Financial Officer
10/09/2025
Buy
$3.79
6,415
$24K
151,770
NASDAQ
BCAX
Bicara Therapeutics
Hyep Ivan
/
officer: Chief Financial Officer
10/09/2025
Sell
$18.23
6,415
$117K
145,355
NASDAQ
BCAX
Bicara Therapeutics
Hyep Ivan
/
officer: Chief Financial Officer
10/09/2025
Sell
$3.79
6,415
$24K
116,584
NASDAQ
BCAX
Bicara Therapeutics
Hyep Ivan
/
officer: Chief Financial Officer
10/07/2025
Buy
$3.79
18,244
$69K
163,599
NASDAQ
BCAX
Bicara Therapeutics
Hyep Ivan
/
officer: Chief Financial Officer
10/06/2025
Buy
$3.79
6,514
$25K
151,869
NASDAQ
BCAX
Bicara Therapeutics
Hyep Ivan
/
officer: Chief Financial Officer
10/08/2025
Buy
$3.79
5,627
$21K
150,982
NASDAQ
BCAX
Bicara Therapeutics
Hyep Ivan
/
officer: Chief Financial Officer
10/06/2025
Sell
$3.79
6,514
$25K
146,870
NASDAQ
BCAX
Bicara Therapeutics
Hyep Ivan
/
officer: Chief Financial Officer
10/06/2025
Sell
$18.17
6,514
$118K
145,355
NASDAQ
BCAX
Bicara Therapeutics
Hyep Ivan
/
officer: Chief Financial Officer
10/08/2025
Sell
$18.21
5,627
$102K
145,355
NASDAQ
BCAX
Bicara Therapeutics
Hyep Ivan
/
officer: Chief Financial Officer
10/07/2025
Sell
$18.22
18,244
$332K
145,355
NASDAQ
BCAX
Bicara Therapeutics
Hyep Ivan
/
officer: Chief Financial Officer
10/07/2025
Sell
$3.79
18,244
$69K
128,626
NASDAQ
BCAX
Bicara Therapeutics
Hyep Ivan
/
officer: Chief Financial Officer
10/08/2025
Sell
$3.79
5,627
$21K
122,999
NASDAQ
BCAX
Bicara Therapeutics
Cohlhepp Ryan
/
director, officer: President and COO
10/06/2025
Buy
$3.79
24,000
$91K
245,141
NASDAQ
BCAX
Bicara Therapeutics
Cohlhepp Ryan
/
director, officer: President and COO
10/06/2025
Sell
$18.06
24,000
$433K
221,141
NASDAQ
BCAX
Bicara Therapeutics
Cohlhepp Ryan
/
director, officer: President and COO
10/07/2025
Buy
$3.79
8,000
$30K
213,541
NASDAQ
BCAX
Bicara Therapeutics
Cohlhepp Ryan
/
director, officer: President and COO
10/07/2025
Sell
$18.06
8,000
$144K
205,541
NASDAQ
BCAX
Bicara Therapeutics
Cohlhepp Ryan
/
director, officer: President and COO
10/06/2025
Sell
$18.06
15,600
$282K
205,541
NASDAQ
BCAX
Bicara Therapeutics
Cohlhepp Ryan
/
director, officer: President and COO
10/07/2025
Sell
$18.06
2,900
$52K
202,641
NASDAQ
BCAX
Bicara Therapeutics
Cohlhepp Ryan
/
director, officer: President and COO
10/06/2025
Sell
$3.79
24,000
$91K
173,334
NASDAQ
BCAX
Bicara Therapeutics
Cohlhepp Ryan
/
director, officer: President and COO
10/07/2025
Sell
$3.79
8,000
$30K
165,334
NASDAQ
BCAX
Bicara Therapeutics
Meisner Lara
/
officer: Chief Legal Officer
09/29/2025
Sell
$9.24
33,807
$312K
101,423
NASDAQ
BCAX
Bicara Therapeutics
Meisner Lara
/
officer: Chief Legal Officer
09/29/2025
Buy
$9.24
33,807
$312K
33,807
NASDAQ
BCAX
Bicara Therapeutics
Meisner Lara
/
officer: Chief Legal Officer
09/29/2025
Sell
$14.75
33,807
$499K
0
NASDAQ
BCAX
Bicara Therapeutics
Meisner Lara
/
officer: Chief Legal Officer
09/15/2025
Sell
$5.45
9,744
$53K
87,699
NASDAQ
BCAX
Bicara Therapeutics
Meisner Lara
/
officer: Chief Legal Officer
09/15/2025
Sell
$5.45
6,085
$33K
54,769
NASDAQ
BCAX
Bicara Therapeutics
Meisner Lara
/
officer: Chief Legal Officer
09/15/2025
Buy
$5.45
15,829
$86K
15,829
NASDAQ
BCAX
Bicara Therapeutics
Meisner Lara
/
officer: Chief Legal Officer
09/15/2025
Sell
$11.49
15,829
$182K
0
Research Tools
Stock Screener
FDA Catalyst Calendar
Insider Transactions
Life Science Stock Lists
All Life Science Stocks
News & Announcements
All Life Science News
Clinical Trial News
Company FDA Updates
Mergers & Acquisitions
Search News & Events
Popular Topics
Top Stocks in 2025
Big Pharma Stocks
Artificial Intelligence
Obesity Drugs
Psychedelic Stocks
Miscellaneous
Free Daily Newsletter
Follow Us On X
Advertise
Privacy Policy
Disclaimer
Tweet
Share
Share
Share
Share
Sign Up To Get Daily
Life Science News
Register
or
Login
to Access Entire Platform.